Cuban’s Cost Plus taps pharma distributor for injectables

USA –  Specialty pharmaceutical distributor Morris & Dickson has joined forces with Mark Cuban Cost Plus Drug Company (MCCPDC) and the Cost Plus Marketplace in a move to tackle drug shortages and reduce costs.

The new partnership aims to improve access to rare and essential injectable medications for hospitals, clinics, surgery centers, and pharmacies across the U.S.

MCCPDC is widely known for offering affordable prescription and over-the-counter medications from suppliers accredited by the National Association of Boards of Pharmacy (NABP).

Through its online platform, the Cost Plus Marketplace, healthcare providers can now purchase medications directly, often at significantly lower prices than traditional channels.

This latest partnership combines MCCPDC’s transparent, cost-plus pricing model with Morris & Dickson’s large distribution network.

The result is a more reliable supply chain, especially for injectable drugs that are frequently in short supply.

These medications are critical for acute care settings, such as emergency rooms and intensive care units, where delays can mean life or death.

Mark Cuban, co-founder of MCCPDC, emphasized that the collaboration is about more than just improving logistics.

“This partnership reshapes the supply chain for injectable medications,” he said. “Together, we’re creating a system that’s transparent, efficient, and focused on the patient.”

Jody Hatcher, CEO of Morris & Dickson, echoed the sentiment, stating that the collaboration could redefine how essential medications are sourced and delivered.

“This is about more than distribution,” Hatcher noted. “It’s about transforming lives and putting pharmacies and patients first.”

The partnership promises flexible purchasing options, no minimum volume requirements, and a simplified buying process through the Cost Plus Marketplace platform.

This is especially helpful for smaller healthcare providers that struggle to meet traditional supplier demands.

A growing movement toward affordable care

This collaboration is just the latest in a series of moves by MCCPDC to make healthcare more affordable.

In 2024, it partnered with eNavvi, a physician-founded online pharmacy, to let doctors prescribe medications directly using a digital prescription pad. This allowed more than 7,000 independent and chain pharmacies to access real-time pricing.

In 2023, MCCPDC teamed up with virtual care provider Wheel, mental health platform Talkspace, and diagnostics firm Health Gorilla to expand low-cost drug access.

Additional partnerships with PharmcoRx Pharmacy and Expion Health helped reduce costs for both generic and specialty medications.

MCCPDC’s reach even extended to elderly caregivers when elderly care app Avanlee Care integrated low-cost drug options into its platform, making it easier for families to manage medications for aging loved ones.